TOTEM RRMS : TestOsterone TreatmEnt on Neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis

Sponsored by University Hospital, Strasbourg, France

Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.

View on ClinicalTrials.gov

Target enrollment

Oct 2019

Start date

Dec 2027

Expected completion

Interventions / Treatments

Nebido® Testosterone Undecanoate 1000 Mg/4 mL Solution for InjectionPlacebo 4 mL Solution for InjectionMRIAssessment of impact of MS on cognition; quality of life; fatigue; anxiety/depression and work and activitiesAssessment of disability

Conditions studied

Multiple Sclerosis, Relapsing-Remitting

Trial locations

U.S. site locations haven't been posted yet for this trial. Check ClinicalTrials.gov for the latest contact and location info.

More Phase 2 trials

Browse all Phase 2 MS trials

The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.